← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 IN8bio INAB $11.5M	19	-3	-14%	$5.55M
77	77 BioCardia BCDA $13.8M	18	-2	-10%	$831K
78	78 FibroBiologics FBLG $6.98M	17	-28	-62%	$291K
79	79 Estrella Immunopharma ESLA $18.9M	16	+1	+7%	$5.49M
80	80 Senti Biosciences Holdings SNTI $7.38M	16	+1	+7%	$4.58M
81	81 Eterna Therapeutics ERNA $2.47M	15	+4	+36%	$711K
82	82 Genprex GNPX $1.8M	15	+6	+67%	$169K
83	83 Pluri PLUR $12.3M	14	-1	-7%	$91.3K
84	84 Creative Medical Technology CELZ $6.04M	11	-3	-21%	$199K
85	85 Genenta Science GNTA $31.8M	11	-4	-27%	$696K
86	86 BioRestorative Therapies BRTX $2.13M	9	-3	-25%	$184K
87	87 NewcelX Ltd NCEL $15.5M	4	+3	+300%	$1.77K
88	ACHL 88 DELISTED Achilles Therapeutics ACHL	3	+1	+50%	$53.3K
89	89 DELISTED Carisma Therapeutics CARM	3	-4	-57%	$47.9K
90	90 CytoMed Therapeutics GDTC $10.5M	3	-2	-40%	$16.3K
91	91 DELISTED Generation Bio GBIO	2	-46	-96%	$53.3K
92	ADAP 92 DELISTED Adaptimmune Therapeutics ADAP	1	-9	-90%	$72
93	ATHX 93 DELISTED Athersys, Inc. Common Stock ATHX	1	0	0%	–
94	94 DELISTED CATALENT, INC. CTLT	1	0	0%	$63
95	95 DELISTED NKGen Biotech, Inc. Common Stock NKGN	1	0	0%	$193K
96	96 DELISTED Scorpius Holdings, Inc. SCPX	1	0	0%	$1
97	ONCS 97 DELISTED OncoSec Medical Incorporated ONCS	0	-1	-100%	–
98	PTE 98 DELISTED PolarityTE, Inc. Common Stock PTE	0	-2	-100%	–
99	99 DELISTED Adverum Biotechnologies ADVM	–	–	–	–
100	AGTC 100 DELISTED Applied Genetic Technologies Corporation AGTC	–	–	–	–